Edward Inns
Private Equity Analist bij Cambridge Innovation Capital Ltd
Oorsprong van het eerstegraads netwerk van Edward Inns
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
University of Oxford
344
| College/University | Other Consumer Services | 344 |
University of Cambridge
243
| College/University | Other Consumer Services | 243 |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.
43
| Private Company | Investment Managers | 43 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Edward Inns via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ARM HOLDINGS PLC | Information Technology Services | Director/Board Member Founder | |
Goldman Sachs International
Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
CSR | Semiconductors | Director/Board Member | |
UK Medical Research Council | Corporate Officer/Principal Corporate Officer/Principal | ||
Cinven Group Ltd.
Cinven Group Ltd. Investment ManagersFinance Cinven Group Ltd (Cinven Group) is a private equity firm founded in 1977. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Analyst Director/Board Member | |
Imperial College London | College/University | Undergraduate Degree Corporate Officer/Principal | |
ECI Partners LLP
ECI Partners LLP Investment ManagersFinance ECI Partners LLP (ECI Partners) is a private equity founded in 1976. The firm is headquartered in London, the United Kingdom with an additional offices in Manchester and New York. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
VMWARE, INC. | Packaged Software | Corporate Officer/Principal | |
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
University of Bristol | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
University College London | College/University | Undergraduate Degree Undergraduate Degree | |
London Business School | College/University | Masters Business Admin | |
The Royal Society of Medicine
The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Investment Managers | Private Equity Investor Director/Board Member Director/Board Member | |
Vantia Ltd.
Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SCIENCE GROUP PLC | Miscellaneous Commercial Services | Director/Board Member | |
FRONTIER DEVELOPMENTS PLC | Recreational Products | Director/Board Member Director/Board Member Founder | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member Founder | |
Organon Laboratories Ltd.
Organon Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Organon Laboratories Ltd. is a company based in Hoddesdon, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member | |
Royal College of Obstetricians & Gynaecologists | College/University | Corporate Officer/Principal | |
Sellsy SASU
Sellsy SASU Packaged SoftwareTechnology Services Easybill SAS provides online customer relationship management and invoice software solutions. It focuses around ERP functionality, such as invoicing. Easybill's features include CRM, teamwork, timetracking, purchases, stocks, help desk, and point of sale. The company was founded by Frédéric Coulais and Alain Mevellec in 2009 and is headquartered in La Rochelle, France. | Packaged Software | Director/Board Member | |
Abcodia Ltd.
Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
St. George's University of London | College/University | Undergraduate Degree | |
KalVista Pharmaceuticals Ltd.
KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Plumis Ltd.
Plumis Ltd. Specialty StoresRetail Trade Plumis Ltd. produces fire protection products for domestic environments. Its product Automist; a simple, retrofittable, sprinkler-alternative for full room active fire protection. In the event of a fire, the system is triggered automatically by a ceiling mounted detector. The company was founded by William Makant, Alan Hart, and Yusuf Muhammad in 2008 and is headquartered in London, the United Kingdom. | Specialty Stores | Director/Board Member | |
Isotera Ltd.
Isotera Ltd. Electrical ProductsProducer Manufacturing Isotera Ltd. provides installation of power supply and control systems for LED lighting. The company is founded by Ian Turner and Marc Hendrik Cornelis Ottolini on August 24, 2010 and is headquartered in London, the United Kingdom. | Electrical Products | Director/Board Member | |
Avilex Pharma ApS
Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
Congenica Ltd.
Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Chairman Director/Board Member Chief Investment Officer Director/Board Member | |
Morphogen-IX Ltd.
Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
CMR Surgical Ltd.
CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Founder Chairman Director/Board Member | |
The World Bank (Research)
The World Bank (Research) Investment ManagersFinance The World Bank (Research) (World Bank-Research) is the investment research division of The World Bank, an international financial institution headquartered in Washington, DC. It provides loans and grants to the governments of low- and middle-income countries for the purpose of pursuing capital projects. World Bank-Research provides research to developing nations to aid economic advancement. | Investment Managers | Economist Economist | |
Budget Insight SAS
Budget Insight SAS Packaged SoftwareTechnology Services Budget Insight SAS provides business-to-business account information and payment initiation services. It offers tools for the management of financial and banking operations. The company was founded by Romain Bignon and Clément Cœurdeuil on February 7, 2012 and is headquartered, Paris, France. | Packaged Software | Director/Board Member | |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
China Civil Aviation (Cayman) Investment Group Ltd.
China Civil Aviation (Cayman) Investment Group Ltd. MiscellaneousMiscellaneous China Civil Aviation (Cayman) Investment Group Ltd. operates as an investment holding company. The company was founded on December 15, 2016 and is headquartered in Cayman Islands. | Miscellaneous | Director/Board Member | |
Sense Biodetection Ltd.
Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Medical/Nursing Services | Chairman Director/Board Member | |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. BiotechnologyHealth Technology MapLight Therapeutics, Inc. engages in the development of novel therapeutics for brain disorders. The company is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | Miscellaneous Commercial Services | Chairman | |
Start Codon Ltd.
Start Codon Ltd. Investment ManagersFinance Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member Director/Board Member | |
Biznet.io SAS
Biznet.io SAS Miscellaneous Commercial ServicesCommercial Services Biznet.io SAS provides resources such as books, studies, events, podcasts, and news to help businesses develop efficiently. The company is based in Paris, France. The French company's platform, Whoz, optimizes internal communication for sales teams and provides real-time analytical insights into commercial pipelines. Whoz also offers a staffing solution for digital service and advice companies to maximize their margin and income by connecting their talent ecosystem to their business. | Miscellaneous Commercial Services | Director/Board Member | |
Pretzel Therapeutics, Inc.
Pretzel Therapeutics, Inc. BiotechnologyHealth Technology Pretzel Therapeutics, Inc. is an American biotechnology company that develops therapies by utilizing mitochondrial biology. Pretzel Therapeutics is based in an undisclosed location and has research facilities in another undisclosed location. The company aims to develop treatments that address the genetic causes of mitochondrial dysfunction. The company was founded by academic experts in mitochondrial biology and is supported by a world-class investor syndicate. Jay Parrish has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Altacor Ltd.
Altacor Ltd. Pharmaceuticals: MajorHealth Technology Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Packaged Software | Director/Board Member |
Statistieken
Internationaal
Verenigd Koninkrijk | 36 |
Verenigde Staten | 11 |
Frankrijk | 4 |
Denemarken | 2 |
Kaaimaneilanden | 2 |
Sectoraal
Health Technology | 17 |
Finance | 8 |
Commercial Services | 8 |
Technology Services | 7 |
Consumer Services | 7 |
Operationeel
Director/Board Member | 271 |
Corporate Officer/Principal | 99 |
Undergraduate Degree | 72 |
Chairman | 71 |
Private Equity Investor | 58 |
Sterkste connecties
Insiders | |
---|---|
Erik Langaker | 46 |
Heiner Dreismann | 46 |
Andrew Richards | 44 |
Jonathan Milner | 26 |
Charles Cotton | 24 |
Steven Leonard | 20 |
Kieran Murphy | 19 |
Robert Tansley | 18 |
John Lee Allen | 16 |
Ted Briscoe | 16 |
Richard Friend | 16 |
Marc Feldmann | 15 |
Gregory Winter | 15 |
Michael Anstey | 14 |
Martin Frost | 14 |
- Beurs
- Insiders
- Edward Inns
- Bedrijfsconnecties